Stocks and Investing
Stocks and Investing
Thu, March 7, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Sung Ji Nam Maintained (BNGO) at Buy with Decreased Target to $6 on, Mar 7th, 2024
Sung Ji Nam of Scotiabank, Maintained "Bionano Genomics, Inc." (BNGO) at Buy with Decreased Target from $7 to $6 on, Mar 7th, 2024.
Sung has made no other calls on BNGO in the last 4 months.
There is 1 other peer that has a rating on BNGO. Out of the 1 peers that are also analyzing BNGO, all agrees with Sung's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jason McCarthy of "Maxim Group" Downgraded from Strong Buy to Hold on, Monday, November 13th, 2023
Contributing Sources